L2 Adult Acute Lymphoblastic Leukemia
1 clinical trials · Condition
◉ Watch L2 Adult Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia (NCT00061945) | National Cancer Institute (NCI) | 2003-06-01 |
Track L2 Adult Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.